comparemela.com

Latest Breaking News On - Adrenocortical carcinoma - Page 1 : comparemela.com

DelveInsight Business Research, LLP: Adrenocortical Carcinoma Market to Exhibit Growth at a CAGR of 11 1% by 2034

Cabozantinib plus Atezolizumab in Locally Advanced/Metastatic Adrenocortical Carcinoma: Results From a Multi-Cohort Basket Phase II Trial (CABATEN/GETNE-T1914)

Enrique Grande, MD, PhD, Msc, presents the results of a multi-cohort basket phase II trial, CABATEN/GETNE-T1914, evaluating cabozantinib plus atezolizumab in patients with locally advanced/metastatic adrenocortical carcinoma.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.